Additional Information

Description

Naloxone HCl, in a concentration of 0.4 mg/mL, supplied in a single-dose vial containing 1 mL of solution, is a critical medication used to reverse the effects of opioid overdose. It functions as a competitive antagonist at opioid receptors, rapidly displacing opioids from receptor sites in the brain and reversing their depressant effects on the central nervous system.

This rapid action can restore normal respiration in individuals experiencing respiratory depression due to opioid overdose, potentially saving lives in emergency situations.The 0.4 mg/mL concentration allows for precise dosing appropriate for reversing opioid effects while minimizing the risk of opioid withdrawal symptoms in affected individuals.

The single-dose vial format ensures sterility and safety for each use, facilitating swift administration in emergency medical settings. Healthcare providers typically administer Naloxone HCl via intravenous, intramuscular, or subcutaneous routes, depending on the severity of the overdose and the patient's condition.

Monitoring patients closely after Naloxone administration is crucial to manage potential adverse effects, including agitation, hypertension, and arrhythmias, especially in individuals with pre-existing cardiac conditions. Rapid access to Naloxone is essential in public health efforts to combat opioid overdose, providing frontline responders and healthcare professionals with an effective tool to intervene promptly and effectively in life-threatening situations involving opioids.